Supply Chain
New research from Advisory Board, conducted in partnership with Staples Business, reveals how 102 health system supply chain and executive…
In a move to expand its cancer immunotherapy pipeline, Merck & Co. inked a deal Wednesday to buy Viralytics, a virus-based cancer drug firm, for 502 million Australian dollars ($394 million), according to Reuters.
Cook Medical, a Bloomington, Ind.-based medical device company, revealed Tuesday it is realigning its global workforce to adapt to today's healthcare needs.
Medtronic CEO Omar Ishrak, PhD, is taking the medical device company in a slightly different direction: accepting more risk in how it gets paid for its products, according to The Wall Street Journal.
Republican Arkansas Governor Asa Hutchinson plans to hold a special legislative session to discuss low reimbursement rates pharmacies receive from pharmacy benefit managers, reports Arkansas Times.
The FDA granted expanded approval for Stryker's Trevo Retriever device Feb. 15.
Amazon quietly launched Basic Care, an exclusive line of 60 over-the-counter healthcare products, in August — a move that could place more pressure on pharmacy retail chains, reports CNBC.
AbbVie, a pharmaceutical company based in North Chicago, Ill., teamed up with Voyager Therapeutics, a clinical-stage gene therapy company, to develop a treatment for neurodegenerative diseases such as Alzheimer's.
Roche Diabetes Care recalled its Accu-Chek Connect diabetes management app over software issues, according to an FDA safety alert issued Feb. 15.
The FDA approved Osmotica Pharmaceutical's drug Osmolex ER to treat Parkinson's disease Monday.
3M Co. recalled 33,108 cases of its underbody warming blankets used to keep patients warm during surgery, according to an FDA safety alert issued Feb. 12.